Key facts
- Explore Investments LLC/DE filed SCHEDULE 13G/A for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL).
- Disclosed ownership: 6.6%.
- Date of event: 31 Mar 2026.
Explore Investments LLC/DE - 31 Mar 2026 SCHEDULE 13G/A Report for Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL)
- Filing Manager
- Explore Investments LLC/DE
- Reporting Manager
- Explore Investments LLC
- Symbol
- LYEL
- Shares outstanding
- 23,167,485 shares
- Disclosed Ownership
- 1,529,054 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 May 2026, 16:23:55 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 19 Aug 2025
- SEC
- View on sec.gov
Key filing fact
Explore Investments LLC/DE disclosed 6.6% ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL) on 31 Mar 2026.
Change
- Previous schedule filing date: 19 Aug 2025.
- Current filing was accepted on 08 May 2026, 16:23.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Explore Investments LLC | 6.6% | 1,529,054 | 0 | 1,529,054 | /s/ Paul Dauber | Paul Dauber/its Manager | |
| Jeffrey P. Bezos | 6.6% | 1,529,054 | 0 | 1,529,054 | /s/ Jeffrey P. Bezos | Jeffrey P. Bezos/an Individual |
CIK / CUSIP context first